Search research articles
Contact Us
Filters
Showing results (481-490 of 1,063) with videos related to
Page
of 107
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2018
Clinical Utility of Cell-Free DNA for the Detection of <i>ALK</i> Fusions and Genomic Mechanisms of ALK Inhibitor Resistance in Non-Small Cell Lung Cancer
Caroline E McCoach, Collin M Blakely, Kimberly C Banks, et al.
Journal of Medicinal Chemistry
|
February 20, 2015
Small molecule binding sites on the Ras:SOS complex can be exploited for inhibition of Ras activation
Jon J G Winter, Malcolm Anderson, Kevin Blades, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 3, 2021
Genotype-Specific Differences in Circulating Tumor DNA Levels in Advanced NSCLC
Vincent K Lam, Jianjun Zhang, Carol C Wu, et al.
ACS Medicinal Chemistry Letters
|
August 18, 2022
Optimization of hERG and Pharmacokinetic Properties for Basic Dihydro-8<i>H</i>-purin-8-one Inhibitors of DNA-PK
Frederick W Goldberg, Attilla K T Ting, David Beattie, et al.
Pacing and Clinical Electrophysiology : PACE
|
December 20, 2016
Evaluation of a Unique Defibrillation Unit with Dual-Vector Biphasic Waveform Capabilities: Towards a Miniaturized Defibrillator
Hideo Okamura, Christopher V Desimone, Ammar M Killu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 2, 2024
Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment
Aparna R Parikh, Bryant H Chee, Jill Tsai, et al.
JCO Precision Oncology
|
October 5, 2020
Identification of Actionable Fusions as an Anti-EGFR Resistance Mechanism Using a Circulating Tumor DNA Assay
Katherine Clifton, Thereasa A Rich, Christine Parseghian, et al.
Molecular Cancer Therapeutics
|
February 28, 2018
Antitumor Activity of Osimertinib, an Irreversible Mutant-Selective EGFR Tyrosine Kinase Inhibitor, in NSCLC Harboring EGFR Exon 20 Insertions
Nicolas Floc'h, Matthew J Martin, Jonathan W Riess, et al.
West African Journal of Medicine
|
November 16, 2023
CASE FATALITY RATE OF CHILDHOOD TUBERCULOSIS: EXPERIENCE FROM FEDERAL TEACHING HOSPITAL GOMBE: A TWO DECADE REVIEW
W E Isaac, I Jalo, G Yohanna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 9, 2020
Routine Plasma-Based Genotyping to Comprehensively Detect Germline, Somatic, and Reversion <i>BRCA</i> Mutations among Patients with Advanced Solid Tumors
Neelima Vidula, Thereasa A Rich, Oliver Sartor, et al.
Page
of 107
Search research articles
Search
Showing results (481-490 of 1,063) with videos related to
Sort By:
Page
of 107
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2018
Clinical Utility of Cell-Free DNA for the Detection of <i>ALK</i> Fusions and Genomic Mechanisms of ALK Inhibitor Resistance in Non-Small Cell Lung Cancer
Caroline E McCoach, Collin M Blakely, Kimberly C Banks, et al.
Journal of Medicinal Chemistry
|
February 20, 2015
Small molecule binding sites on the Ras:SOS complex can be exploited for inhibition of Ras activation
Jon J G Winter, Malcolm Anderson, Kevin Blades, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 3, 2021
Genotype-Specific Differences in Circulating Tumor DNA Levels in Advanced NSCLC
Vincent K Lam, Jianjun Zhang, Carol C Wu, et al.
ACS Medicinal Chemistry Letters
|
August 18, 2022
Optimization of hERG and Pharmacokinetic Properties for Basic Dihydro-8<i>H</i>-purin-8-one Inhibitors of DNA-PK
Frederick W Goldberg, Attilla K T Ting, David Beattie, et al.
Pacing and Clinical Electrophysiology : PACE
|
December 20, 2016
Evaluation of a Unique Defibrillation Unit with Dual-Vector Biphasic Waveform Capabilities: Towards a Miniaturized Defibrillator
Hideo Okamura, Christopher V Desimone, Ammar M Killu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 2, 2024
Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment
Aparna R Parikh, Bryant H Chee, Jill Tsai, et al.
JCO Precision Oncology
|
October 5, 2020
Identification of Actionable Fusions as an Anti-EGFR Resistance Mechanism Using a Circulating Tumor DNA Assay
Katherine Clifton, Thereasa A Rich, Christine Parseghian, et al.
Molecular Cancer Therapeutics
|
February 28, 2018
Antitumor Activity of Osimertinib, an Irreversible Mutant-Selective EGFR Tyrosine Kinase Inhibitor, in NSCLC Harboring EGFR Exon 20 Insertions
Nicolas Floc'h, Matthew J Martin, Jonathan W Riess, et al.
West African Journal of Medicine
|
November 16, 2023
CASE FATALITY RATE OF CHILDHOOD TUBERCULOSIS: EXPERIENCE FROM FEDERAL TEACHING HOSPITAL GOMBE: A TWO DECADE REVIEW
W E Isaac, I Jalo, G Yohanna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 9, 2020
Routine Plasma-Based Genotyping to Comprehensively Detect Germline, Somatic, and Reversion <i>BRCA</i> Mutations among Patients with Advanced Solid Tumors
Neelima Vidula, Thereasa A Rich, Oliver Sartor, et al.
Page
of 107